AR and prostate cancer: Firstly, leveraging the anchorage-independent growth characteristic of cancer stem cells, we isolated and enriched the putative PCSCs from three prostate cancer cell lines differing in their AR expression status (AR-positive: LNCaP, AR-negative: DU145 and PC3) using an agar-based non-adhesion method [27].